Listed

Creative Medical Technology Holdings, Inc.: Form 10-Q for the period ended Sep 30, 2019

Filed with the SEC on Nov 14, 2019 and accepted by EDGAR at Nov 14, 2019, 16:46 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2019-07-01 to 2019-09-30$57.5kus-gaap:Revenues
Revenue9 months2019-01-01 to 2019-09-30$169.9kus-gaap:Revenues
Cost of revenue3 months2019-07-01 to 2019-09-30$8.0kus-gaap:CostOfRevenue
Cost of revenue9 months2019-01-01 to 2019-09-30$41.4kus-gaap:CostOfRevenue
Gross profit3 months2019-07-01 to 2019-09-30$49.5kus-gaap:GrossProfit
Gross profit9 months2019-01-01 to 2019-09-30$128.5kus-gaap:GrossProfit
Research and development3 months2019-07-01 to 2019-09-30$0us-gaap:ResearchAndDevelopmentExpense
Research and development9 months2019-01-01 to 2019-09-30$0us-gaap:ResearchAndDevelopmentExpense
Operating income3 months2019-07-01 to 2019-09-30−$273.4kus-gaap:OperatingIncomeLoss
Operating income9 months2019-01-01 to 2019-09-30−$799.6kus-gaap:OperatingIncomeLoss
Interest expense3 months2019-07-01 to 2019-09-30$529.2kus-gaap:InterestExpense
Interest expense9 months2019-01-01 to 2019-09-30$1.5mus-gaap:InterestExpense
Income tax3 months2019-07-01 to 2019-09-30$0us-gaap:IncomeTaxExpenseBenefit
Income tax9 months2019-01-01 to 2019-09-30$0us-gaap:IncomeTaxExpenseBenefit
Net income3 months2019-07-01 to 2019-09-30−$2.4mus-gaap:NetIncomeLoss
Net income9 months2019-01-01 to 2019-09-30−$3.3mus-gaap:NetIncomeLoss
Operating cash flow9 months2019-01-01 to 2019-09-30−$960.7kus-gaap:NetCashProvidedByUsedInOperatingActivities
Current assetsAt period end2019-09-30$182.7kus-gaap:AssetsCurrent
Total assetsAt period end2019-09-30$330.4kus-gaap:Assets
Current liabilitiesAt period end2019-09-30$3.9mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2019-09-30$3.9mus-gaap:Liabilities
Long-term debtAt period end2019-09-30$1.5mus-gaap:LongTermDebt
Shareholders' equityAt period end2019-09-30−$3.6mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001104659-19-064296. Last ingested by Listed: Nov 14, 2026, 19:08 ET. Listed shows no prices and gives no investment advice.